(Q43654862)

25 November 2017

Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo (English)

1 reference

25 November 2017

0 references

9

Trappe J

1 reference

25 November 2017

Weber O

1

1 reference

25 November 2017

Bender W

2

1 reference

25 November 2017

Eckenberg P

3

1 reference

25 November 2017

Goldmann S

4

1 reference

25 November 2017

Haerter M

5

1 reference

25 November 2017

Hallenberger S

6

1 reference

25 November 2017

Henninger K

7

1 reference

25 November 2017

Reefschläger J

8

1 reference

25 November 2017

Witt-Laido A

10

1 reference

25 November 2017

Ruebsamen-Waigmann H

11

1 reference

25 November 2017

language of work or name

1 reference

1 March 2001

1 reference

25 November 2017

1 reference

25 November 2017

49

1 reference

25 November 2017

3

1 reference

25 November 2017

179-189

1 reference

Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Summary of the II International Symposium on Cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

In vivo drug screening applications of HIV-infected cells cultivated within hollow fibers in two physiologic compartments of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

In vivo cultivation of tumor cells in hollow fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Effect of acyclovir and phosphonoformate on cytomegalovirus infection in guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for the treatment of murine cytomegalovirus infection in severe combined immunodeficiency mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Impact of cytomegalovirus infection on organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Cytomegalovirus and the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Novel mouse models for the investigation of experimental drugs with activity against human varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

Efficacy of BMS-180194 against experimental cytomegalovirus infections in immunocompromised mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900127-9

7 January 2021

10.1016/S0166-3542(01)00127-9

Identifiers

DOI

1 reference

25 November 2017

1 reference